Coalition Launches $62 Million Initiative to Develop Ebola Vaccines Amid Outbreak in Congo
A global coalition has been established to expedite the development of three vaccines targeting the Ebola virus, which is currently spreading in Congo, with a funding commitment of $62 million.
Editorial Staff
1 min read
Updated 10 days ago
In response to the ongoing Ebola outbreak in the Congo, a coalition has formed to accelerate the development of vaccines against the virus.
Currently, there are no licensed vaccines available for Ebola, highlighting the urgency of this initiative.
The coalition's efforts are backed by a significant funding allocation of $62 million aimed at advancing research and development in this critical area.